New Device Developed at UBC Could Improve Cancer Detection
May 12, 2016 | University of British ColumbiaEstimated reading time: 1 minute
A new UBC-developed method to isolate cancer cells that have escaped from a tumour could soon pave the way for improved diagnosis and treatment.
The simple process involves a special device that squeezes cells in a blood sample through tiny funnels, which drive the cancer cells and blood cells into separate streams based on differences in their size and softness.
"Circulating tumour cells--cells from a tumour that have escaped into the bloodstream with the potential to spread into other tissues--are extremely useful for assessing a patient's disease in order to select the most appropriate treatment," said UBC mechanical engineering professor Hongshen Ma, the lead researcher. "These cells are particularly important for prostate cancer, where the site of metastasis is typically in the bone, where biopsies are difficult or impossible."
Ma's research focus is microfluidics, the flow of liquids through channels smaller than a human hair. The microfluidic device designed by his team captures cells based on their distinct internal structure--a mechanical analysis instead of the blood chemistry analysis used in conventional medical diagnostic techniques.
The device was first tested using blood samples spiked with cancer cells. It was then used to analyze blood samples from 20 patients with metastatic castration-resistant prostate cancer, an advanced form of cancer, and from four healthy individuals.
"In the first experiment, the device was able to capture more than 90 per cent of the cells," noted co-author Dr. Kim N. Chi, director of clinical research at the B.C. Cancer Agency and a professor of medicine at UBC. "Importantly, in patient samples the device captured about 25 times the number of cancer cells and produced fewer false positives compared to the conventional CellSearch system, which also analyzes blood samples."
The team is currently working on genome sequencing of individual circulating tumour cells from patients at the Vancouver Prostate Centre. This would allow researchers to determine the mutations responsible for metastasis so that doctors can select the most appropriate treatment.
Suggested Items
Boeing Opens Research & Technology Center in Japan
04/23/2024 | BoeingBoeing today opened a Boeing Research & Technology (BR&T) Center in Japan that will focus on innovation to enable the commercial aviation industry meet its goal of net zero carbon emissions by 2050.
Gartner Forecasts Worldwide IT Spending to Grow 8% in 2024
04/17/2024 | Gartner, Inc.Worldwide IT spending is expected to total $5.06 trillion in 2024, an increase of 8% from 2023, according to the latest forecast by Gartner, Inc. This is an increase from the previous quarter’s forecast of 6.8% growth and puts worldwide IT spending on track to surpass $8 trillion well before the end of the decade.
Argonne, RIKEN Sign a Memorandum of Understanding in Support of AI for Science
04/16/2024 | BUSINESS WIRELeaders in high performance computing in the U.S. and Japan have signed a memorandum of understanding (MOU) establishing a cooperative relationship in support of artificial intelligence (AI) computing projects.
RAICo Fellowship to Widen Participation Within the Field of Robotics and Artificial Intelligence
04/12/2024 | RAICoWOMEN and those early in their academia career who are passionate about robotics and artificial intelligence are encouraged to apply for a RAICo Fellowship.
Indium to Host Free Webinar on Lead-Free Solder Paste for Automotive Applications
04/09/2024 | Indium CorporationIndium Corporation’s Senior Research Metallurgist, Jie Geng, Ph.D., will conduct a webinar on low-voiding, high-reliability, lead-free solder paste for automotive applications.